Atherosclerosis is one of those Step 1 “small concept, huge consequences” topics: you can understand it in an afternoon, but it explains stable angina, MI, stroke, PAD, aneurysms, and a ton of pharmacology and pathology vignettes. If you can tell a clean story—endothelial injury → lipid entry/oxidation → inflammation → foam cells → smooth muscle migration → fibrous cap—you’ll crush most coronary/ischemic heart disease questions built on this foundation.
Where this fits (and why it’s Step 1 gold)
Atherosclerosis is a chronic, inflammatory disease of medium and large arteries driven by lipid accumulation and endothelial dysfunction, culminating in plaque formation and either:
- Progressive luminal narrowing → predictable ischemia (e.g., stable angina)
- Acute plaque disruption with thrombosis → infarction (e.g., MI, stroke)
First Aid cross-reference (general):
- Pathology → Atherosclerosis
- Cardiovascular → Ischemic heart disease/MI, Angina
- Pharm → Statins, antiplatelets, antihypertensives
Definition (use the buzzwords)
Atherosclerosis = intimal thickening with:
- Lipid core (cholesterol, foam cells, necrotic debris)
- Fibrous cap (smooth muscle cells + collagen)
- Chronic inflammation (macrophages, T cells)
Key distinction: This is a type of arteriosclerosis (hardening of arteries). Other “-sclerosis” entities you must not confuse:
- Arteriolosclerosis (hyaline/hyperplastic) → HTN/DM, small vessels
- Monckeberg medial calcific sclerosis → calcified media, usually benign
Pathogenesis: the Step 1 “movie plot”
You’ll see questions that give risk factors + a plaque complication and ask “what’s happening at the cellular level?” Here’s the high-yield sequence.
1) Endothelial injury/dysfunction (the trigger)
Common causes:
- Hypertension (shear stress)
- Hyperlipidemia (especially ↑ LDL)
- Cigarette smoking
- Diabetes mellitus
- Inflammation (e.g., elevated CRP), toxins, homocystinuria (less common but tested)
What dysfunctional endothelium does:
- ↑ permeability to lipoproteins
- ↑ leukocyte adhesion (VCAM-1 etc.)
- ↓ NO (less vasodilation, more platelet aggregation)
- Pro-thrombotic state (less antithrombotic signaling)
HY vignette clue: long-standing HTN + smoker + high LDL → “endothelial dysfunction with increased permeability to lipoproteins.”
2) LDL enters the intima and becomes oxidized
- LDL migrates into the intima and gets oxidized.
- Oxidized LDL is pro-inflammatory and chemoattractant.
Why oxidized LDL matters (testable):
- Promotes macrophage uptake via scavenger receptors (unregulated)
- Stimulates cytokines → more inflammation
- Toxic to endothelium → worsens dysfunction
3) Monocytes adhere → become macrophages → foam cells
- Monocytes migrate into intima → macrophages.
- Macrophages ingest oxidized LDL → foam cells.
- Foam cells aggregate → fatty streaks.
Fatty streaks
- Earliest visible lesion
- Can be seen in youth
- May progress to plaques (especially with risk factors)
4) Smooth muscle migration + proliferation + ECM deposition
- Smooth muscle cells migrate from media → intima (stimulated by growth factors like PDGF).
- They proliferate and secrete collagen + extracellular matrix → builds the fibrous cap.
Core Step 1 point: plaques are not just “fat”; they are active inflammatory lesions with smooth muscle and collagen.
5) Mature atheromatous plaque
Final structure:
- Fibrous cap (collagen + SMC)
- Necrotic lipid core (cholesterol, foam cells, debris)
- “Shoulder” region with inflammatory cells (often the weak point)
Stable vs vulnerable plaques (how Step questions trick you)
Not all plaques behave the same.
| Feature | Stable plaque | Vulnerable (unstable) plaque |
|---|---|---|
| Fibrous cap | Thick | Thin |
| Lipid core | Smaller | Large |
| Inflammation | Less | More macrophages/T cells |
| Main consequence | Chronic luminal narrowing → stable angina | Rupture/erosion → thrombosis → MI/unstable angina |
| Clinical pattern | Predictable exertional symptoms | Often at rest, acute events |
HY punchline: The plaque that causes an acute MI is often not the biggest stenosis—it’s the most rupture-prone.
Complications (very testable)
Atherosclerosis causes problems via stenosis or plaque change.
1) Progressive stenosis → chronic ischemia
- Stable angina (exertional chest pain relieved by rest/nitro)
- Chronic mesenteric ischemia (“intestinal angina”)
- Peripheral artery disease (claudication)
2) Plaque rupture/erosion → thrombosis → infarction
- MI (coronary thrombosis)
- Ischemic stroke (carotid plaque rupture/embolization)
- Acute limb ischemia
Mechanism: exposed subendothelial collagen + tissue factor → platelet activation and coagulation.
3) Cholesterol embolization
- Plaque debris showers downstream, often after vascular procedures.
- Can cause livedo reticularis, “blue toe,” AKI.
4) Aneurysm formation (especially abdominal aorta)
- Atherosclerosis weakens vessel wall (ischemia of media) → AAA
- Classic association: smoking, male, older age
First Aid tie-in: AAA and atherosclerosis are frequent neighbors in FA cardiovascular pathology sections.
Coronary & ischemic heart disease: clinical presentation link
Atherosclerosis is the upstream disease that sets the stage for the big coronary syndromes.
Stable angina (demand ischemia)
- Fixed stenosis (often >70%) limits flow during exertion.
- Subendocardium is most vulnerable (highest wall stress, farthest from epicardial vessels).
Acute coronary syndrome (ACS)
Triggered by plaque disruption:
- Unstable angina: ischemia at rest; no troponin rise
- NSTEMI: subendocardial infarct; troponins up, ST depression/T inversion
- STEMI: transmural infarct; ST elevation, Q waves later
High-yield mechanistic link: ACS = thrombus on disrupted plaque, not simply “a plaque got bigger overnight.”
Risk factors (know the categories)
Non-modifiable
- Age
- Male sex (risk rises in women after menopause)
- Family history/genetics
Modifiable (HY)
- Hyperlipidemia (↑ LDL, ↓ HDL)
- Hypertension
- Smoking
- Diabetes mellitus
- Obesity, sedentary lifestyle
Lipid pearls that show up in vignettes
- LDL = atherogenic (delivers cholesterol to tissues)
- HDL = protective (reverse cholesterol transport)
- Familial hypercholesterolemia (LDL receptor/ApoB-100 issues) → early CAD, tendon xanthomas
Diagnosis (what do you actually “see”?)
Atherosclerosis itself is often silent until it causes ischemia. Diagnosis focuses on:
- Risk assessment: lipids, diabetes screening, BP, smoking history
- Evidence of ischemia: ECG changes, stress testing, troponins in ACS
- Anatomic assessment (when indicated): coronary CTA, angiography
Pathology gross description (Step-style):
- Raised, yellow-white intimal plaques
- Complicated lesions may show hemorrhage, ulceration, superimposed thrombus, calcification
Treatment: prevention + plaque stabilization + thrombosis prevention
Think in 3 lanes: risk factor modification, lipid lowering, antithrombotic therapy.
1) Lifestyle (always correct, often “best next step”)
- Smoking cessation
- Diet changes (lower saturated/trans fats)
- Exercise and weight loss
- Diabetes control, BP control
2) Statins (core pharmacology tie-in)
Mechanism: inhibit HMG-CoA reductase → ↓ cholesterol synthesis → ↑ LDL receptor expression → ↓ LDL
Why Step exams love statins in atherosclerosis:
- Lower LDL and reduce cardiovascular events
- Plaque “stabilization” concept (reduced inflammation, improved endothelial function—clinically meaningful even if simplified for Step)
Classic adverse effects: myopathy, ↑ LFTs (and rare rhabdo risk, higher with fibrates/niacin interactions)
3) Antiplatelets (especially secondary prevention)
- Aspirin (COX inhibition → ↓ TXA2)
- P2Y12 inhibitors (e.g., clopidogrel) in ACS/post-stent contexts
4) BP and diabetes management
- Reduces endothelial injury and progression
5) Acute plaque rupture/ACS management (big picture)
- Antiplatelets + anticoagulation + reperfusion strategy when indicated (PCI/thrombolysis for STEMI)
(You’ll cover detailed ACS algorithms elsewhere—here the key is that the acute event is thrombosis on a disrupted plaque.)
High-yield associations & “classic vignette” tells
Pathogenesis buzzwords to recognize
- “Endothelial dysfunction” + “oxidized LDL” + “foam cells”
- “Fatty streak” in a young person (early lesion)
- “Thin fibrous cap with large lipid core” → rupture-prone plaque
- “Superimposed thrombus” → acute coronary syndrome
Common boards-style pairings
- Smoking → AAA and worsening atherosclerosis
- DM → accelerated atherosclerosis, often multi-vessel CAD
- HTN → endothelial injury and plaque progression
- Familial hypercholesterolemia → early MI, tendon xanthomas, corneal arcus
Frequently confused concepts (quick clarifiers)
- Atherosclerosis is intimal and lipid-driven; hyaline arteriolosclerosis is small-vessel thickening from HTN/DM.
- Stable angina is fixed stenosis; unstable angina/MI is plaque disruption + thrombosis.
Rapid review table (Step 1 speed mode)
| Concept | Must-know takeaway |
|---|---|
| Initiating event | Endothelial injury/dysfunction (HTN, smoking, DM, hyperlipidemia) |
| Early lesion | Fatty streak = foam cells in intima |
| Key inflammatory step | Oxidized LDL → macrophage uptake via scavenger receptors |
| Growth step | SMC migration/proliferation + collagen → fibrous cap |
| Stable plaque | Thick cap → chronic narrowing → stable angina |
| Vulnerable plaque | Thin cap, big lipid core → rupture → thrombosis → MI |
| Major complications | Stenosis, thrombosis, embolization, aneurysm |
Final Step 1 takeaway (the one-sentence story)
Atherosclerosis is a chronic inflammatory response to endothelial injury where LDL enters and oxidizes, macrophages become foam cells, smooth muscle lays down a fibrous cap, and the clinical disaster happens when a vulnerable plaque ruptures and triggers thrombosis—especially in the coronaries.